Orthotopic bone formation by implantation of apatite‐coated poly(lactide‐co‐glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein‐2
- 7 January 2008
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 87A (1), 245-253
- https://doi.org/10.1002/jbm.a.31782
Abstract
Bone morphogenetic proteins (BMPs) are the most potent osteoinductive growth factors. However, a delivery system is essential to take advantage of the osteoinductive effect of BMPs. In the present study, we tested the suitability of apatite-coated poly(D,L-lactide-co-glycolide)/nanohydroxyapatite (PLGA/HA) particulates as carriers for the controlled release of BMP-2. The release of BMP-2 from apatite-coated PLGA/HA particulates was sustained for at least 4 weeks in vitro. A delivery system of apatite-coated PLGA/HA particulates suspended in fibrin gel further slowed the BMP-2 release rate. In vivo implantation of either Fibrin gel + BMP-2 or Fibrin gel + apatite-coated PLGA/HA particulates showed enhanced new bone formation in critical-sized calvarial defects of rats 8 weeks after implantation, compared to implantation of fibrin gel only. Importantly, new bone formation was much higher in the defects treated with BMP-2 delivery using apatite-coated PLGA/HA particulates in fibrin gel (Fibrin gel + PLGA/HA + BMP-2 group) than in the defects treated either with apatite-coated PLGA/HA particulates in fibrin gel (Fibrin gel + BMP-2 group) or with BMP-2 delivery using fibrin gel alone (Fibrin gel + BMP-2 group). BMP-2 and osteoinductive HA had an additive effect on orthotopic bone formation. In conclusion, the apatite-coated PLGA/HA particulates showed good results as carriers for BMP-2. The BMP-2 delivery system showed high osteogenic capability in a rat calvarial bone defect model. The local and sustained delivery system for BMP-2 developed in this study may be useful as a carrier for BMP-2 and would enhance bone regeneration efficacy for the treatment of large bone defects. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2008This publication has 23 references indexed in Scilit:
- The effect of a fibrin-fibronectin/β-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defectsBiomaterials, 2006
- Comparison of BMP‐2 and ‐4 for rat mandibular bone regeneration at various doses1Orthodontics & Craniofacial Research, 2005
- On the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug deliveryJournal of Controlled Release, 2005
- Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphateBiomaterials, 2005
- Effects of MgO‐CaO‐P2O5‐Na2O‐based additives on mechanical and biological properties of hydroxyapatiteJournal of Biomedical Materials Research Part A, 2004
- Biomimetic Polymer/Apatite Composite Scaffolds for Mineralized Tissue EngineeringMacromolecular Bioscience, 2004
- Hydroxyapatite particles as a controlled release carrier of proteinBiomaterials, 2003
- Formation of biologically active bone-like apatite on metals and polymers by a biomimetic processThermochimica Acta, 1996
- Resorbable synthetic polymers s replacements for bone graftClinical Materials, 1994
- The History of Bone GraftsPublished by Ovid Technologies (Wolters Kluwer Health) ,1988